Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.

Selänne L, Haijanen J, Sippola S, Hurme S, Rautio T, Nordström P et al.

Sellappan H, Alagoo D, Loo C, Vijian K, Sibin R, Chuah JA.

Popeskou SG, Roesel R, Faes S, Vanoni A, Galafassi J, di Tor Vajana AF et al.

Ann Surg 2024; 279: 196-202.

Thirty-four patients with symptomatic low anterior resection syndrome (LARS) were included. Those randomized to Ondansetron first had improved LARS scores, whereas those who had Ondansetron second, tended to have deteriorating scores. Treatment was safe.

Comment: Good treatment for an unpleasant condition.